Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

β-blockers can cause skin problems like psoriasis and vitiligo, and doctors should tell patients about these risks.

The research concluded that selection significantly shaped the genetic variation of the X chromosome, with certain regions affected by past selective events.

PI3K/Akt pathway is crucial for hair growth and regeneration.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Artificial skin is improving wound healing and shows potential for treating different types of wounds.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

A girl initially thought to have a psychiatric disorder was later found to have a lupus-related condition, which improved with proper treatment.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Microneedle technology is beneficial for drug delivery and could make vaccinations cheaper and more accessible.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Stem cell technologies and regenerative medicine, including platelet-rich plasma, show promise for hair restoration in treating hair loss, but more research is needed.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Oral minoxidil effectively treats hair loss, with women needing lower doses (0.25 to 2.5 mg daily) and men needing higher doses (1.25 to 5 mg daily).

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.